Prognostic Significance ofp53andX-ray Repair Cross-complementing Group 1Polymorphisms on Prostate-Specific Antigen Recurrence in Prostate Cancer Post–Radical Prostatectomy
- 15 November 2007
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 13 (22) , 6632-6638
Abstract
Purpose: The tumor suppressor p53 and DNA repair gene X-ray repair cross-complementing group 1 (XRCC1) are thought to play important roles on prostate cancer susceptibility and tumor development. We investigated the potential prognostic roles of p53 (codon 72) and XRCC1 (codons 194, 280, and 399) polymorphisms in clinical localized prostate cancer after radical prostatectomy. Experimental Design: A total of 126 clinical localized prostate cancer patients undergoing curative radical prostatectomy at the Kaohsiung Medical University Hospital and Kaohsiung Veterans General Hospital were included in this study. The p53 codon 72 and XRCC1 codons 194, 280 and 399 polymorphisms were determined by the PCR-RFLP method. Their prognostic significance on prostate-specific antigen (PSA) recurrence were assessed using the Kaplan-Meier analysis and Cox regression model. Results: The p53 codon 72 Arg/Arg genotype was associated with increased PSA recurrence risk compared with the Arg/Pro and Pro/Pro genotypes, although the difference did not reach significance (30.3% versus 20.4%, P = 0.247). Of these three XRCC1 polymorphisms, the codon 399 Arg/Gln + Gln/Gn genotypes were significantly associated with higher risk of PSA recurrence after radical prostatectomy compared with the Arg/Arg genotype (34.0% versus 15.1%, P = 0.013) and poorer PSA-free survival (log-rank test, P = 0.0056). After considering for other covariates in a Cox proportional hazard model, the XRCC1 Arg/Gln and Gln/Gln genotypes (hazard ratio, 4.73; 95% confidence interval, 1.61-13.92; P = 0.005) and high Gleason score (Gleason score, 8-10; hazard ratio, 5.58; 95% confidence interval, 1.58-19.71; P = 0.008) were still independent predictors of poor PSA-free survival after radical prostatectomy. The similar significant results were not found in XRCC1 codons 194 and 280. Conclusions: Our results suggest that the XRCC1 codon 399 polymorphism may be a prognostic factor for PSA recurrence after radical prostatectomy.Keywords
This publication has 43 references indexed in Scilit:
- Polymorphisms of DNA repair genes are risk factors for prostate cancerEuropean Journal of Cancer, 2007
- Time to Prostate Specific Antigen Recurrence After Radical Prostatectomy and Risk of Prostate Cancer Specific MortalityJournal of Urology, 2006
- Single nucleotide polymorphisms in DNA repair genes might be prognostic factors in muscle-invasive bladder cancer patients treated with chemoradiotherapyBritish Journal of Cancer, 2006
- Polymorphisms in Genes of Nucleotide and Base Excision Repair: Risk and Prognosis of Colorectal CancerClinical Cancer Research, 2006
- XRCC1Polymorphisms and Cancer Risk: A Meta-analysis of 38 Case-Control StudiesCancer Epidemiology, Biomarkers & Prevention, 2005
- BIOCHEMICAL FAILURE IN MEN FOLLOWING RADICAL RETROPUBIC PROSTATECTOMY: IMPACT OF SURGICAL MARGIN STATUS AND LOCATIONJournal of Urology, 2004
- Association between vitamin D receptor polymorphisms and prostate cancer risk in a Taiwanese populationCancer Letters, 2004
- PREDICTING RISK OF PROSTATE SPECIFIC ANTIGEN RECURRENCE AFTER RADICAL PROSTATECTOMY WITH THE CENTER FOR PROSTATE DISEASE RESEARCH AND CANCER OF THE PROSTATE STRATEGIC UROLOGIC RESEARCH ENDEAVOR DATABASESJournal of Urology, 2001
- P53 codon 72 polymorphism in a taiwanese lung cancer population: Correlation with lung cancer susceptibility and prognosisToxicology Letters, 1998
- The p53 tumour suppressor geneNature, 1991